Annovis Bio, Inc. (ANVS) SEC Filings — 2025
18 SEC filings for Annovis Bio, Inc. (ANVS) in 2025.
Filings
- Annovis Bio Files 8-K on Financials — 8-K · Nov 13, 2025
- Annovis Bio Narrows Q3 Loss, Raises Capital Amid Going Concern Doubts — 10-Q · Nov 12, 2025
- Annovis Bio Files 8-K — 8-K · Oct 28, 2025
- Annovis Bio, Inc. Files 8-K for Material Definitive Agreement — 8-K · Oct 14, 2025
- Annovis Bio Appoints New CMO, Elects Director — 8-K · Sep 29, 2025
- Annovis Bio: CEO Shifts to CSO, New CMO Appointed — 8-K · Aug 15, 2025
- Annovis Bio Files 8-K on Operations — 8-K · Aug 12, 2025
- Annovis Bio's Q2 Losses Widen Amid R&D Push — 10-Q · Aug 12, 2025
- Annovis Bio Files 8-K on Shareholder Votes & Financials — 8-K · Jun 23, 2025
- Annovis Bio Files Current Report — 8-K · Jun 20, 2025
- Annovis Bio Files 8-K on Financials and Personnel — 8-K · May 13, 2025
- Annovis Bio Files Q1 2025 10-Q — 10-Q · May 13, 2025
- Annovis Bio Files Proxy Statement for Shareholder Meeting — DEFA14A · May 1, 2025
- Annovis Bio Files Proxy Statement for June Meeting — DEF 14A · Apr 30, 2025
- Annovis Bio 8-K: Delisting Notice, Director Changes, Officer Appointments — 8-K · Mar 27, 2025
- Annovis Bio Files 8-K on Financials — 8-K · Mar 21, 2025
- Annovis Bio Files 2024 10-K — 10-K · Mar 21, 2025
- Annovis Bio Enters Material Definitive Agreement — 8-K · Feb 5, 2025